Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
21.77
+0.22 (1.02%)
Apr 8, 2026, 3:04 PM CST
Market Cap11.76B +28.7%
Revenue (ttm)3.42B +13.5%
Net Income96.34M
EPS0.18
Shares Out540.16M
PE Ratio120.94
Forward PE58.84
Dividendn/a
Ex-Dividend Daten/a
Volume14,880,879
Average Volume10,190,858
Open21.99
Previous Close21.55
Day's Range21.46 - 22.13
52-Week Range12.31 - 30.40
Beta0.70
RSI51.08
Earnings DateApr 4, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. The company o... [Read more]

Sector Healthcare
Founded 2005
Employees 4,200
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements